UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 416

Sortiert nach

Oligoprogression in Non-Small Cell Lung Cancer

Cancers, 2021-11, Vol.13 (22), p.5823

2021

Link zum Volltext

Verfügbarkeit prüfen

The Role of STAT3 in Non-Small Cell Lung Cancer

Cancers, 2014-03, Vol.6 (2), p.708-722

2014

Link zum Volltext

Verfügbarkeit prüfen

De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor

Journal of the American Chemical Society, 2019-12, Vol.141 (49), p.19193-19197

2019

Link zum Volltext

Verfügbarkeit prüfen

Non-Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (6), p.1506-1516

2016

Link zum Volltext

Verfügbarkeit prüfen

The complexity of EGFR exon 19 deletion and L858R mutant cells as assessed by proteomics, transcriptomics, and metabolomics

Experimental cell research, 2023-03, Vol.424 (1), p.113503-113503, Article 113503

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical application of a lung cancer organoid (tumoroid) culture system

NPJ precision oncology, 2021-04, Vol.5 (1), p.29-29, Article 29

2021

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer

Cancers, 2015-04, Vol.7 (2), p.763-783

2015

Link zum Volltext

Verfügbarkeit prüfen

Pneumocystis jirovecii pneumonia mortality risk associated with preceding long-term steroid use for the underlying disease: A multicenter, retrospective cohort study

PloS one, 2024-02, Vol.19 (2), p.e0292507-e0292507

2024

Link zum Volltext

Verfügbarkeit prüfen

Novel Germline Mutation in the Transmembrane Domain of HER2 in Familial Lung Adenocarcinomas

JNCI : Journal of the National Cancer Institute, 2014-01, Vol.106 (1), p.djt338-djt338

2014

Link zum Volltext

Verfügbarkeit prüfen

Practical Advanced Care Planning for Patients with Thoracic Cancer

Haigan, 2023/06/20, Vol.63(3), pp.147-152

2023

Link zum Volltext

Verfügbarkeit prüfen

Successful Treatment of Non-small-cell Lung Cancer with Atezolizumab Following Tubulointerstitial Nephritis Due to Pembrolizumab

Internal Medicine, 2020/07/01, Vol.59(13), pp.1639-1642

2020

Link zum Volltext

Verfügbarkeit prüfen

Subpopulation of small‐cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy

Cancer science, 2013-01, Vol.104 (1), p.78-84

2013

Link zum Volltext

Verfügbarkeit prüfen

Predictive Factors for the Efficacy of Immune Checkpoint Inhibitors Against Lung Cancer

Haigan, 2022/10/20, Vol.62(5), pp.355-362

2022

Link zum Volltext

Verfügbarkeit prüfen

A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401

Supportive care in cancer, 2021-09, Vol.29 (9), p.5237-5244

2021

Link zum Volltext

Verfügbarkeit prüfen

Erythema as a Visual Surrogate Marker of Glucagonoma

Internal Medicine, 2018/08/01, Vol.57(15), pp.2283-2284

2018

Link zum Volltext

Verfügbarkeit prüfen

Emergence of epidermal growth factor receptor T790M mutation during chronic exposure to gefitinib in a non-small cell lung cancer cell line

Cancer research (Chicago, Ill.), 2007-08, Vol.67 (16), p.7807-7814

2007

Link zum Volltext

Verfügbarkeit prüfen

Cytotoxic Anticancer Agents

Annals of oncology, 2019-10, Vol.30, p.vi57

Takigawa, Nagio

2019

Link zum Volltext

Verfügbarkeit prüfen

Establishment and characterization of novel high mucus-producing lung tumoroids derived from a patient with pulmonary solid adenocarcinoma

Human cell : official journal of Human Cell Research Society, 2024, Vol.37 (4), p.1194-1204

2024

Link zum Volltext

Verfügbarkeit prüfen

Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systemic Review

PloS one, 2011-11, Vol.6 (11), p.e26646

2011

Link zum Volltext

Verfügbarkeit prüfen

Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review

PloS one, 2011-11, Vol.6 (11), p.e26646-e26646

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of a Cyclooxygenase-2 Inhibitor in Combination with (-)-Epigallocatechin Gallate or Polyphenon E on Cisplatin-Induced Lung Tumorigenesis in A/J Mice

Acta medica Okayama, 2023-02, Vol.77 (1), p.65-70

2023

Link zum Volltext

Verfügbarkeit prüfen

First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study

Journal of cancer research and clinical oncology, 2022-08, Vol.148 (8), p.1869-1877

2022

Link zum Volltext

Verfügbarkeit prüfen

Lower gefitinib dose led to earlier resistance acquisition before emergence of T790M mutation in epidermal growth factor receptor‐mutated lung cancer model

Cancer science, 2013-11, Vol.104 (11), p.1440-1446

2013

Link zum Volltext

Verfügbarkeit prüfen

Reappraisal of short-term low-volume hydration in cisplatin-based chemotherapy: results of a prospective feasibility study in advanced lung cancer in the Okayama Lung Cancer Study Group Trial 1002

Japanese journal of clinical oncology, 2013-11, Vol.43 (11), p.1115-1123

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 416

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(334)
Mit Volltextzugriff
(389)

Publikationsform

Sprache

Englisch
(375)
Japanisch
(109)

Erscheinungsjahr

n.n

Thema

Science & Technology
(257)
Life Sciences & Biomedicine
(249)
Humans
(219)
Oncology
(195)
Female
(148)
Male
(135)
Aged
(113)
Lung Neoplasms - Drug Therapy
(112)
Middle Aged
(111)
Lung Cancer
(97)
Biological And Medical Sciences
(87)
Medical Sciences
(87)
Lung Neoplasms - Pathology
(84)
Respiratory System
(75)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(69)
Adult
(68)
Tumors
(65)
Pneumology
(61)
Tumors Of The Respiratory System And Mediastinum
(57)
Lung Neoplasms - Genetics
(51)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(38)
Cancer Research
(35)
Anticancer Research
(21)
Journal Of Clinical Oncology
(19)
Journal Of Thoracic Oncology
(18)
Internal Medicine
(16)
Haigan. Lung Cancer
(15)
Japanese Journal Of Clinical Oncology
(14)
Acta Medica Okayama
(12)
Haigan
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Oligoprogression in Non-Small Cell Lung Cancer

The Role of STAT3 in Non-Small Cell Lung Cancer

De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor

Non-Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases

The complexity of EGFR exon 19 deletion and L858R mutant cells as assessed by proteomics, transcriptomics, and metabolomics

Clinical application of a lung cancer organoid (tumoroid) culture system

Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer

Pneumocystis jirovecii pneumonia mortality risk associated with preceding long-term steroid use for the underlying disease: A multicenter, retrospective cohort study

Novel Germline Mutation in the Transmembrane Domain of HER2 in Familial Lung Adenocarcinomas

Practical Advanced Care Planning for Patients with Thoracic Cancer

Successful Treatment of Non-small-cell Lung Cancer with Atezolizumab Following Tubulointerstitial Nephritis Due to Pembrolizumab

Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007

Subpopulation of small‐cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy

Predictive Factors for the Efficacy of Immune Checkpoint Inhibitors Against Lung Cancer

A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401

Erythema as a Visual Surrogate Marker of Glucagonoma

Emergence of epidermal growth factor receptor T790M mutation during chronic exposure to gefitinib in a non-small cell lung cancer cell line

Cytotoxic Anticancer Agents

Establishment and characterization of novel high mucus-producing lung tumoroids derived from a patient with pulmonary solid adenocarcinoma

Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systemic Review

Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review

Effect of a Cyclooxygenase-2 Inhibitor in Combination with (-)-Epigallocatechin Gallate or Polyphenon E on Cisplatin-Induced Lung Tumorigenesis in A/J Mice

First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study

Lower gefitinib dose led to earlier resistance acquisition before emergence of T790M mutation in epidermal growth factor receptor‐mutated lung cancer model

Reappraisal of short-term low-volume hydration in cisplatin-based chemotherapy: results of a prospective feasibility study in advanced lung cancer in the Okayama Lung Cancer Study Group Trial 1002

Suchergebnisse filtern